Opiant Pharmaceuticals Inc
3 clinical trials · Sponsor
◉ Watch Opiant Pharmaceuticals Inc
| Record | Firm | Date |
|---|---|---|
| Pharmacokinetic Evaluation of Intranasal Nalmefene Using Three Dosing Regimens (NCT05219669) | Opiant Pharmaceuticals Inc | 2021-09-01 |
| Pharmacodynamic Evaluation of Intranasal Nalmefene (NCT04828005) | Opiant Pharmaceuticals Inc | 2021-03-30 |
| Pharmacokinetic Evaluation of Intranasal Nalmefene (NCT04759768) | Opiant Pharmaceuticals Inc | 2021-02-08 |
Track Opiant Pharmaceuticals Inc automatically
Every clearance here is in the API, with alerts when new ones post.